Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Depreciation and Depletion (2023 - 2025)

Historic Depreciation and Depletion for MDxHealth (MDXH) over the last 3 years, with Q3 2025 value amounting to $957000.0.

  • MDxHealth's Depreciation and Depletion rose 1656.52% to $957000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 4913.45%. This contributed to the annual value of $3.1 million for FY2024, which is 3251.59% up from last year.
  • According to the latest figures from Q3 2025, MDxHealth's Depreciation and Depletion is $957000.0, which was up 1656.52% from $946000.0 recorded in Q2 2025.
  • MDxHealth's 5-year Depreciation and Depletion high stood at $957000.0 for Q3 2025, and its period low was -$1.7 million during Q4 2024.
  • Its 3-year average for Depreciation and Depletion is $233875.0, with a median of $779000.0 in 2023.
  • Its Depreciation and Depletion has fluctuated over the past 5 years, first plummeted by 1524.97% in 2024, then skyrocketed by 4014.81% in 2025.
  • MDxHealth's Depreciation and Depletion (Quarter) stood at -$1.5 million in 2023, then decreased by 15.25% to -$1.7 million in 2024, then surged by 156.03% to $957000.0 in 2025.
  • Its last three reported values are $957000.0 in Q3 2025, $946000.0 for Q2 2025, and $925000.0 during Q1 2025.